Explore our new brand identity
Tell Congress to Oppose Price Setting
Biocom California is the indisputable leader in accelerating life science in California. We accelerate our members’ success by advocating for innovation, removing barriers to doing business, and connecting people, talent, and capital. We represent a place where revolutionary research is routine and fearless innovation is business as usual. A home for those with the audacity to think they can change the world. Because California is more than a spot on the map—it’s a state of mind. A state of progress.
H.R.3 is an international reference pricing measure introduced in the House of Representatives. The bill proposes setting prices for innovative medicines in the U.S based on the prices foreign countries with different health care systems pay for those medicines. Importing price controls would threaten the development of new treatments and cures and jeopardize patient access to medicines.
Passing H.R.3 threaten California’s world-class innovative biopharmaceutical sector, decreasing the development of new treatments and cures for patients around the world. Biocom California strongly opposes H.R.3 and has advocated against its progress on behalf of our member organizations.
Take advantage of 30+ RFP-vetted life science-related contracts.
See the data on returning to face-to-face gatherings.
Read our response to the White House’s support of the proposal.
Explore the California life science industry’s go-to career resource.
Get to know our growing list of 1,400+ member companies.
